HRQOL of Life After ECMO Due to COVID-19.

Health-related Quality of Life Following Extracorporeal Membrane Oxygenation Due to Coronavirus Disease 2019.

Status

Completed

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT05531032

Enrollment

Registered

2022-09-07

Start date

2022-08-30

Completion date

2024-10-31

Last updated

2025-04-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

ARDS, COVID-19 Pneumonia, Extracorporeal Membrane Oxygenation

Brief summary

We intend to prospectively investigate physical and mental state (HRQOL) by means of quantitative telephone interviews after hospital discharge in patients surviving COVID-19 ARDS and ECMO therapy.

Interventions

OTHERPhone Interview

Phone interview questionnaire

Study design

Allocation

Intervention model

SINGLE_GROUP

Primary purpose

HEALTH_SERVICES_RESEARCH

Masking

NONE

Intervention model description

Phone Interview

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* patients surviving COVID-19 ARDS and ECMO therapy

Exclusion criteria

* no consent

Design outcomes

Primary

Measure	Time frame	Description
HRQOL after COVID-19 ARDS and ECMO therapy	1 year	Health-related quality of life will be delineated by means of a quantitative questionnaire.

Countries

Austria

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026